EverPoint Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCA
JWA
AIC
BFA
MCM
WA
MIP
TCM
EverPoint Asset Management's IRMD Position: Q2 2016 in Review
EverPoint Asset Management sold out of iRadimed (IRMD) in Q2 2016, closing a stake of 48,282 shares — an estimated $925K sold.
EverPoint Asset Management first reported a position in IRMD in Q4 2015 and held it in 2 quarters. The position peaked at $1.35M in Q4 2015. 60 funds tracked by Wall St. Rank hold IRMD as of Q2 2016.
- EverPoint Asset Management reported no remaining iRadimed position as of Q2 2016 after selling out during the quarter.
- EverPoint Asset Management sold 48,282 iRadimed shares in Q2 2016, an estimated $925K.
- EverPoint Asset Management first reported a position in iRadimed in Q4 2015 and held it in 2 quarters.
- EverPoint Asset Management's iRadimed position peaked at $1.35M in Q4 2015.
- 60 funds tracked by Wall St. Rank held iRadimed as of Q2 2016.
Based on EverPoint Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.